Core Viewpoint - The Xinjiang Guzhangui Biotechnology Co., Ltd. is under investigation for alleged false advertising related to its camel milk products, following a report revealing discrepancies in product content and health claims [1][3]. Group 1: Company Actions and Responses - The Xinjiang Fukang City Market Supervision Administration has initiated an investigation into Guzhangui, with results to be publicly announced later [1]. - Following the report, Guzhangui has removed the implicated products, including "Camel Milk Tablets" and "Children's Growth Camel Milk Powder," from its online store [9]. - The company's official WeChat accounts have also been cleared of content promoting health benefits associated with camel milk [3]. Group 2: Product Claims and Marketing Practices - A report indicated that a product labeled as "Camel Milk Tablets" contained less than 10% camel milk powder, with the majority being cow milk powder [1]. - The company has made claims about camel milk's benefits for conditions like hypertension and diabetes, suggesting it can aid in disease management, which has been criticized by legal and nutrition experts as misleading [2][3]. - A nutritionist associated with Guzhangui claimed that camel milk could help manage blood pressure and suggested prolonged consumption for health benefits, further promoting the product through a referral system [2]. Group 3: Company Background and Market Position - Guzhangui claims to be a pioneer in camel milk products in China and has been a top seller in the camel milk product category for three consecutive years, with reported sales of 10 million items over three years [13]. - The company was established in 2024 and is primarily owned by individuals with connections to multiple companies in Henan, despite being registered in Xinjiang [13].